One of our researchers recently spoke at a conference on stroke research.

One of our researchers recently spoke at a conference on stroke research.
Dr Abed Islim, an NIHR Academic Clinical Fellow (ACF) in neurosurgery at Salford Care Organisation, has been elected president of the British Neurosurgical Trainees Research Collaborative.
A new patient and public involvement and engagement (PPIE) project is seeking members of the public to complete a survey.
Yolanda Ohene, Neuroimaging Scientist at the University of Manchester, and Laura Parkes, the Centre’s joint theme lead for imaging, recently organised a mentor scheme to encourage underrepresented groups into medical imaging.
April marks the first anniversary of the scientific launch of the Geoffrey Jefferson Brain Research Centre. We want to thank you all for your support, encouragement, engagement, and activity over the past year.
Specialist Nurse for skull base tumours at Salford Royal, Andrea Wadeson, has reflected on her experience of the British Association of Neuroscience Nursing (BANN) Nurse Fellowship exchange in a new article in a leading journal.
Dr Claire Howard is a stroke/neuro specialist research orthoptist based at Salford Royal hospital, part of the Northern Care Alliance NHS Foundation Trust. She completed an NIHR Clinical Doctorate Research fellowship in 2020 in collaboration with the VISION research...
Congratulations to Claire Mitchell who has been awarded a Stroke Association Post-Doctoral Fellowship. Claire is a speech and language therapist and senior clinical lecturer on the BSc Speech and Language Therapy course at The University of Manchester. The fellowship...
A seventh theme has been added to the ever expanding Centre. The Parkinson's theme will be led by Professor Monty Silverdale. Professor Silverdale and his colleagues were recently awarded the Royal Society of Chemistry prize for their pioneering NoseToDiagnose work,...
A new transatlantic partnership between the Centre and NF2 BioSolutions will support research to find an effective treatment for neurofibromatosis type 2. It is hoped that the research programme will lead to repurposing existing drugs to benefit patients with the...
Recent Comments